Skip to content

Clinical trials

Gender Dysphoria trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gender Dysphoria Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20182
20194
20203
20213
20225
20231
20244
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6
Terminated5
Unknown status2
Not yet recruiting2
Enrolling by invitation2
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of California, San Francisco3
University of Colorado, Denver3
University of Wisconsin, Madison3
University of Pittsburgh2
Cedars-Sinai Medical Center1
Dartmouth-Hitchcock Medical Center1
Duke University1
Fenway Community Health1
MaineHealth1
Mountain Dermatology Specialists1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gender Dysphoria29
Acquired Immunodeficiency Syndrome2
Infertility2
Insulin Resistance2
Agnosia1
Alcoholism1
Anxiety Disorders1
Asperger Syndrome1
Attention Deficit Disorder with Hyperactivity1
Autistic Disorder1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.